Food News and Research

RSS

FDA clears Curemark's CM – 4612 IND for Phase III clinical trial in ADHD

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the U.S. Food and Drug Administration has given clearance to Curemark's Investigational New Drug application for a Phase III clinical trial for the use of CM – 4612 in the treatment of attention deficit hyperactivity disorder.

11 Aug 2010

FDA approves longer Valcyte therapy for CMV disease in adult kidney transplant patients

Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) approved increasing the length of therapy with Valcyte (valganciclovir hydrochloride) in adult kidney transplant patients at high risk for cytomegalovirus (CMV) disease.

11 Aug 2010

Vertex reports results from Phase 3 ILLUMINATE study of telaprevir-based therapy for hepatitis C

Vertex Pharmaceuticals Incorporated today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).

10 Aug 2010

Analysis finds no evidence that inclusion of retinyl palmitate in sunscreens can cause cancer

Despite previous concerns about the cancer-causing potential of sunscreens containing retinyl palmitate (vitamin A), an independent analysis published online in the Journal of the American Academy of Dermatology determined that there is no evidence that the inclusion of retinyl palmitate in sunscreens can cause cancer in humans.

10 Aug 2010

FDA grants Orphan Drug Designation to YM BioSciences' JAK1/2 inhibitor

YM BioSciences Inc., announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration has granted Orphan Drug Designation to the Company's highly-selective JAK1/2 inhibitor, CYT387, for the treatment of myelofibrosis, a chronic debilitating unmet medical need, in which a patient's bone marrow is replaced by scar tissue, and for which treatment options are limited or unsatisfactory.

10 Aug 2010

First Edition: August 10, 2010

In today's news, the House is back in town... though just for a day. Lawmakers will consider a state aid package that includes $16 billion in federal Medicaid assistance.

10 Aug 2010

IMUSA invites community to take advantage of free diabetes screenings, healthy diabetes-friendly recipes

IMUSA, the leading brand of Hispanic housewares in North America, in conjunction with The American Diabetes Association and local health organizations, invite the community to take advantage of free diabetes screenings, meet and greet popular Hispanic Chef Elsie Ramos, and sample healthy diabetes-friendly recipes.

10 Aug 2010

Census Bureau releases schedule for 2009 income, poverty and health insurance estimates

The Census Bureau announced today the public release schedule for the official income, poverty and health insurance estimates for 2009 from the Current Population Survey (CPS), as well as estimates from the American Community Survey (ACS).

10 Aug 2010

Al Shabaab demands World Vision to close operations in Somalia

World Vision Somalia received a demand today from Al Shabaab to close operations in Somalia. World Vision guards were disarmed and their keys were taken. Nothing was removed from the offices although Al Shabaab representatives occupied the offices.

10 Aug 2010

New method for tracing brain circuits

The brain has been mapped to the smallest fold for at least a century, but still no one knows how all the parts talk to each other.

10 Aug 2010

Beryl Institute publishes White paper on patient experience from different healthcare organizations

The Beryl Institute has published a new White Paper, Zeroing in on the Patient Experience: Views and Voices from the Frontlines, which takes a close look into the efforts of three patient experience leaders from different healthcare organizations. The White Paper covers what it takes to launch and sustain patient experience efforts and includes practical advice and tips for hospitals that want to begin to focus on improving the patient experience.

10 Aug 2010

FDA approves human embryonic stem cells clinical trial for spinal cord injury treatment

Emerging Healthcare Solutions, Inc.: Last week, the US Food and Drug Administration gave their highly-anticipated approval for the first clinical trial using human embryonic stem cells (hESCs), which are the type of cells that can develop into all tissues of the body. Geron Corporation of Menlo Park, California, received the green light from the US FDA to use cells derived from hESCs to treat people with acute spinal cord injuries. Ten people will receive injections into the injury site of hESC-derived oligodendrocyte progenitor cells, which stimulate the growth of new and severed nerves and recoat damaged nerves with myelin. The hope is that the injections will help people recover function lost through injury, as seen in rodent studies in 2005.

10 Aug 2010

Transcept Pharmaceuticals second-quarter net loss decreases to $2.06 million

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three and six months ended June 30, 2010.

10 Aug 2010

ADA updates position paper on children’s healthy behaviors

The American Dietetic Association has published an updated position paper on local support for nutrition integrity in schools that calls on schools and communities to work together to provide healthful and affordable meals for all children and to promote educational environments that help students learn and practice healthy behaviors for their entire lives.

10 Aug 2010

Endo to acquire Penwest for $5.00 per share

Endo Pharmaceuticals today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close. Penwest has been working with Endo since 1997 on the development and commercialization of OPANA® ER and receives a royalty stream on net sales of the product.

10 Aug 2010

Medivation net loss decreases from $8.9M in second-quarter 2010 to $7.2M in second-quarter 2011

Medivation, Inc. today provided a corporate update and reported its financial results for the second quarter ended June 30, 2010.

10 Aug 2010

Cardium second-quarter net loss decreases to $0.7 million

Cardium Therapeutics today reported highlights and financial results for its second quarter ended June 30, 2010.

10 Aug 2010

Ikaria announces voluntary recall of INOMAX DS drug-delivery system in US and Canada

Ikaria, Inc. announced today that its INOMAX® DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX® (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of its ongoing quality monitoring and review processes. This class I recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). All INOMAX DS systems in Canada also are being voluntarily recalled.

10 Aug 2010

House members returning for vote on extra Medicaid help

House members are returning to Washington for a Tuesday vote on $16 billion in extra Medicaid funds for cash-strapped states, The Associated Press reports. "The unusual in-and-out session was called because the Senate waited until last Thursday, after the House had already recessed for its summer break" to pass the bill, which includes $10 billion in state aid for teachers' jobs, too. "Republicans forced back to the Capitol to vote against a bill see it differently.

10 Aug 2010

U.N. says nearly 14M Pakistanis affected by floods

On Monday the U.N. said that 13.8 million people have been affected by the floods in Pakistan as the death toll has now reached 1,600, Agence France-Presse reports.

9 Aug 2010

Food News and Research

FDA clears Curemark's CM – 4612 IND for Phase III clinical trial in ADHD

FDA approves longer Valcyte therapy for CMV disease in adult kidney transplant patients

Vertex reports results from Phase 3 ILLUMINATE study of telaprevir-based therapy for hepatitis C

Analysis finds no evidence that inclusion of retinyl palmitate in sunscreens can cause cancer

FDA grants Orphan Drug Designation to YM BioSciences' JAK1/2 inhibitor

First Edition: August 10, 2010

IMUSA invites community to take advantage of free diabetes screenings, healthy diabetes-friendly recipes

Census Bureau releases schedule for 2009 income, poverty and health insurance estimates

Al Shabaab demands World Vision to close operations in Somalia

New method for tracing brain circuits

Beryl Institute publishes White paper on patient experience from different healthcare organizations

FDA approves human embryonic stem cells clinical trial for spinal cord injury treatment

Transcept Pharmaceuticals second-quarter net loss decreases to $2.06 million

ADA updates position paper on children’s healthy behaviors

Endo to acquire Penwest for $5.00 per share

Medivation net loss decreases from $8.9M in second-quarter 2010 to $7.2M in second-quarter 2011

Cardium second-quarter net loss decreases to $0.7 million

Ikaria announces voluntary recall of INOMAX DS drug-delivery system in US and Canada

House members returning for vote on extra Medicaid help

U.N. says nearly 14M Pakistanis affected by floods

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News